Last reviewed · How we verify
NCT07425457: CRYO-TKA
Cryoneurolysis Prior to Total Knee Arthroplasty (CRYO-TKA Trial)
NA trial testing CT-guided Cryoneurolysis of the Genicular Nerves in Arthroplasty in 100 participants. Currently enrolling.
31 December 2027
Quick facts
| Lead sponsor | Attikon Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 2 January 2026 |
| Primary completion | 31 December 2027 |
| Estimated completion | 31 March 2028 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- CT-guided Cryoneurolysis of the Genicular Nerves
Conditions studied
- Arthroplasty — all drugs for Arthroplasty →
- Replacement Material — all drugs for Replacement Material →
- Knee Arthritis Osteoarthritis — all drugs for Knee Arthritis Osteoarthritis →
- Knee Arthroplasty, Total — all drugs for Knee Arthroplasty, Total →
Sponsor
Attikon Hospital
Who can join
18 and older, any sex, with Arthroplasty or Replacement Material. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Approximately 20-30% of patients experience persistent pain after a Total Knee Arthroplasty (TKA). This study investigates whether percutaneous cryoneurolysis of genicular nerves can reduce pain and improve physical function when performed at least 24 hours before surgery. Participants will be randomized to receive either the cryoneurolysis procedure + TKA or TKA only. Results will be tracked for 6 months to see if the intervention improves long-term recovery and quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07425457
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Arthroplasty
Currently open trials in the same condition.
- NCT06323980 — INHANCE Stemless Reverse Shoulder IDE · NA · recruiting
- NCT04848896 — Study to Evaluate the Safety and Effectiveness of the REAL INTELLIGENCE™ CORI™ in Total Knee Arthroplasty (TKA) Procedur · NA · recruiting
- NCT04849884 — To Evaluate the Performance of the CORI™ KNEE TENSIONER as an Accessory to the CORI™ Surgical System. · NA · active not recruiting
- NCT05190666 — Healthy Living After Knee Replacement · NA · active not recruiting
Other Attikon Hospital trials
Trials by the same sponsor.
- NCT06646107 — Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There · recruiting
- NCT06810700 — The Association Between Time in Range With Markers of Endothelial and Cardiovascular Function · not yet recruiting
- NCT06978387 — The Association Between Glycemic Metrics and Cardiovascular Markers in Patients With Type 1 Diabetes. · active not recruiting
- NCT06749613 — Digestive Enzyme Formulation Intervention in IBS Patients Who Previously Clinically Responded to Mediterranean LFD · NA · recruiting
- NCT07467642 — A Neuromodulation Auditory System to Optimize Patient Experience During Dysfunctional Dialysis Access Endovascular Proce · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07425457 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Attikon Hospital
- Last refreshed: 20 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07425457.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing